SNOA
Sonoma Pharmaceuticals Inc
NASDAQ: SNOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.10
+3.77% today
Updated 2026-04-30
Market cap
$4.98M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-1.95
Dividend yield
—
52W range
$1 – $7
Volume
0.2M
Sonoma Pharmaceuticals Inc (SNOA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-149.7%
Last 4 quarters
Revenue YoY growth
+22.0%
Most recent quarter
EPS YoY growth
+23.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-2.1%
2026-02-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-10 | $-0.48 | -860.0% | $2.91 | $2.85 | -2.1% |
| 2025-11-04 | $-0.32 | -540.0% | $3.78 | $3.76 | -0.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.05 | $-0.48 | -860.0% | $4.35M | +22.0% |
| 2025-09-30 | $-0.05 | $-0.32 | -540.0% | $5.60M | +56.6% |
| 2025-06-30 | $-0.51 | $-0.76 | -49.0% | $4.01M | +18.4% |
| 2025-03-31 | $-0.04 | $-0.48 | -1100.0% | $3.75M | +9.2% |
| 2024-12-31 | $-0.60 | $-0.63 | -5.0% | $3.56M | +13.6% |
| 2024-09-30 | $-0.80 | $-0.59 | +26.3% | $3.58M | +31.1% |
| 2024-06-30 | $-0.06 | $-0.07 | -16.7% | $3.39M | -1.1% |
| 2024-03-31 | $-0.17 | $-0.07 | +58.8% | $3.44M | +14.1% |
| 2023-12-31 | $-0.21 | $-0.08 | +61.9% | $3.14M | — |
| 2023-09-30 | $-0.24 | $-0.29 | -20.8% | $2.73M | — |
| 2023-06-30 | $-0.12 | $-0.28 | -133.0% | $3.43M | — |
| 2023-03-31 | $-0.23 | $-0.31 | -34.8% | $3.01M | — |
Frequently asked questions
Has Sonoma Pharmaceuticals Inc beaten earnings estimates?
Sonoma Pharmaceuticals Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -149.7% over the last 3 quarters.
How does SNOA stock react to earnings?
SNOA stock has moved an average of -1.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Sonoma Pharmaceuticals Inc's revenue growth rate?
Sonoma Pharmaceuticals Inc reported year-over-year revenue growth of +22.0% in its most recent quarter, with EPS growing +23.8% year-over-year.